LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Search

DaVita Inc

Cerrado

SectorSanidad

199.49 3.68

Resumen

Variación precio

24h

Actual

Mínimo

190.25

Máximo

199.53

Métricas clave

By Trading Economics

Ingresos

-804M

275M

Ventas

-204M

3.4B

P/B

Media del Sector

19.165

51.415

BPA

2.87

Margen de beneficios

8.052

Empleados

78,000

EBITDA

-62M

655M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+9.56% upside

Dividendos

By Dow Jones

Próximas Ganancias

4 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.6B

13B

Apertura anterior

195.81

Cierre anterior

199.49

Noticias sobre sentimiento de mercado

By Acuity

52%

48%

274 / 345 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

DaVita Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 06:30 UTC

Adquisiciones, fusiones, absorciones

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

Comparación entre iguales

Cambio de precio

DaVita Inc previsión

Precio Objetivo

By TipRanks

9.56% repunte

Estimación a 12 Meses

Media 211 USD  9.56%

Máximo 235 USD

Mínimo 194 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DaVita Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

142.36 / 144.275Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

274 / 345 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.